Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Ventyx Biosciences, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Ventyx Biosciences is a clinical-stage biopharmaceutical company developing oral immunology therapies for inflammatory diseases and autoimmune disorders. The company focuses on creating selective small molecule drugs that modulate immune pathways with improved safety and efficacy profiles. Ventyx is advancing multiple programs targeting conditions such as psoriasis, inflammatory bowel disease, and other immune-mediated diseases.